Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
16.84
+0.05 (0.30%)
At close: May 13, 2025, 4:00 PM
16.68
-0.16 (-0.95%)
Pre-market: May 14, 2025, 5:17 AM EDT
Pulse Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
75
Market Cap
1.13B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PLSE News
- 3 days ago - Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - Business Wire
- 7 days ago - Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference - Business Wire
- 12 days ago - Pulse Biosciences' Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting - Business Wire
- 18 days ago - Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 19 days ago - Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 - Business Wire
- 20 days ago - Pulse Biosciences' Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting - Business Wire
- 6 weeks ago - Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript - Seeking Alpha